知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

55 records (took 0.057 seconds)

    Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof
    13.
    发明授权
    Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof 失效
    吡唑并吡啶酮和吡唑并吡嗪酮化合物作为P38调节剂及其使用方法

    公开(公告)号：US08435987B2

    公开(公告)日：2013-05-07

    申请号：US13197322

    申请日：2011-08-03

    Applicant: Liping H. Pettus ,  Andrew Tasker ,  Shimin Xu ,  Ryan Wurz

    Inventor： Liping H. Pettus ,  Andrew Tasker ,  Shimin Xu ,  Ryan Wurz

    IPC: A61K31/437 ,  A61K31/4985 ,  A61K31/5377 ,  C07D487/04 ,  C07D471/04 ,  A61P19/02 ,  A61P29/00 ,  A61P19/08 ,  A61P19/10 ,  A61P35/00 ,  A61P1/00 ,  A61P17/00

    CPC classification number: C07D471/04 ,  C07D487/04

    Abstract: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A1, A2, B, R1, R2, R4, R5, R6 and Z are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of P38 map kinase mediated diseases including rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease, pain and other inflammatory disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.

    Abstract translation: 本发明包括一类新的可用于预防和治疗蛋白激酶介导的疾病，包括炎症和相关病症的化合物。 该化合物具有通式I，其中A1，A2，B，R1，R2，R4，R5，R6和Z如本文所定义。 本发明还包括药物组合物，其包含一种或多种式I化合物，用于治疗P38地图激酶介导的疾病（包括类风湿性关节炎，牛皮癣，慢性阻塞性肺病，疼痛和其它炎症性疾病）的这些化合物和组合物的用途以及中间体 和可用于制备式I化合物的方法。

    Pyrazolo-pyridinone compounds and methods of use thereof
    15.
    发明授权
    Pyrazolo-pyridinone compounds and methods of use thereof 有权
    吡唑并吡啶酮化合物及其使用方法

    公开(公告)号：US07846944B2

    公开(公告)日：2010-12-07

    申请号：US12151478

    申请日：2008-05-06

    Applicant: Liping Pettus ,  Andrew Tasker ,  Shimin Xu ,  Ryan Wurz

    Inventor： Liping Pettus ,  Andrew Tasker ,  Shimin Xu ,  Ryan Wurz

    IPC: C07D487/04 ,  A01N43/42 ,  A61K31/44

    CPC classification number: C07D471/04

    Abstract: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A1, A2, A3, A4, B, R1, R2, R3, R4 and R5 are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of P38 map kinase mediated diseases including rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease, pain and other inflammatory disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.

    Abstract translation: 本发明包括一类新的可用于预防和治疗蛋白激酶介导的疾病，包括炎症和相关病症的化合物。 化合物具有通式I，其中A1，A2，A3，A4，B，R1，R2，R3，R4和R5如本文所定义。 本发明还包括药物组合物，其包含一种或多种式I化合物，用于治疗P38地图激酶介导的疾病（包括类风湿性关节炎，牛皮癣，慢性阻塞性肺病，疼痛和其它炎症性疾病）的这些化合物和组合物的用途以及中间体 和可用于制备式I化合物的方法。

    VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
    16.
    发明申请
    VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS 失效
    VANILLOID受体配体及其在治疗中的应用

    公开(公告)号：US20090143575A1

    公开(公告)日：2009-06-04

    申请号：US12367352

    申请日：2009-02-06

    Applicant: Chenera Balan ,  Yunxin Bo ,  Celia Dominguez ,  Christopher H. Fotsch ,  Vijay K. Gore ,  Vu Van Ma ,  Mark H. Norman ,  Vassil I. Ognyanov ,  Yi-xin Qian ,  Xianghong Wang ,  Ning Xi ,  Shimin Xu

    Inventor： Chenera Balan ,  Yunxin Bo ,  Celia Dominguez ,  Christopher H. Fotsch ,  Vijay K. Gore ,  Vu Van Ma ,  Mark H. Norman ,  Vassil I. Ognyanov ,  Yi-xin Qian ,  Xianghong Wang ,  Ning Xi ,  Shimin Xu

    IPC: C07D413/14 ,  C07D471/04 ,  C07D401/14

    CPC classification number: C07D401/04 ,  C07D235/30 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D403/14 ,  C07D405/14 ,  C07D409/14 ,  C07D417/12 ,  C07D417/14 ,  C07D471/04

    Abstract: Therapeutic benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotizing agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

    Abstract translation: 治疗性苯并咪唑和含有它们的组合物，用于治疗急性，炎性和神经性疼痛，牙痛，一般头痛，偏头痛，丛集性头痛，混合血管和非血管综合征，紧张性头痛，一般炎症，关节炎，风湿性疾病，骨关节炎 ，炎症性肠病，炎症性眼病，炎症性或不稳定性膀胱病，银屑病，皮肤炎症成分炎症，慢性炎性病症，炎性疼痛及相关的痛觉过敏和异常性疼痛，神经性疼痛及相关的痛觉过敏和异常性疼痛，糖尿病性神经病疼痛，灼痛，交感神经痛 维持疼痛，输血综合征，哮喘，上皮组织损伤或功能障碍，单纯疱疹，呼吸道，泌尿生殖道，胃肠道或血管区内脏运动紊乱，伤口，烧伤，过敏性皮肤反应，瘙痒，白癜风，一般胃肠道疾病，胃溃疡 十二指肠溃疡，腹泻，坏死因子诱发的胃损伤，毛发生长，血管舒缩或过敏性鼻炎，支气管疾病或膀胱疾病。

Patent Agency Ranking